China Pharma Holdings (CPHI) Enterprise Value (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Enterprise Value came in at -$168474.0 in Q1 2026, up 59.18% YoY from -$105841.1 in Q1 2025, and up 51.18% on a QoQ basis from -$345112.0 in Q4 2025.
China Pharma Holdings (CPHI) Enterprise Value (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Enterprise Value data on file, last reported at -$168474.0 in Q1 2026.
- Quarterly Enterprise Value rose 59.18% year-over-year to -$168474.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$168474.0 (up 59.18% YoY) and the FY2025 annual result came in at -$345112.0, up 44.95% from the prior year.
- Enterprise Value rose to -$168474.0 in Q1 2026, from -$345112.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$168474.0 in Q1 2026 to a low of -$3.7 million in Q1 2022.
- A 5-year average of -$1.2 million and a median of -$838881.0 in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 594.97% — and 2023, when it surged 68.59%.
- Tracing CPHI's Enterprise Value over 5 years: stood at -$2.0 million in 2022, then increased by 29.86% to -$1.4 million in 2023, then soared by 55.97% to -$626879.0 in 2024, then surged by 44.95% to -$345112.0 in 2025, then surged by 51.18% to -$168474.0 in 2026.
- The last three Enterprise Value figures came in at -$168474.0 (Q1 2026), -$345112.0 (Q4 2025), and -$267625.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | -304,874.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168,474.00 |
| Dec 31, 2025 | -345,112.00 |
| Sep 30, 2025 | -267,625.00 |
| Jun 30, 2025 | -625,032.00 |
| Mar 31, 2025 | -412,688.00 |
| Dec 31, 2024 | -626,879.00 |
| Sep 30, 2024 | -718,691.00 |
| Jun 30, 2024 | -739,337.00 |
| Mar 31, 2024 | -838,881.00 |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -1.37 Mn |
| Jun 30, 2023 | -901,910.00 |
| Mar 31, 2023 | -1.17 Mn |
| Dec 31, 2022 | -2.03 Mn |
| Sep 30, 2022 | -2.10 Mn |
| Jun 30, 2022 | -2.20 Mn |
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2021 | -4.86 Mn |
| Sep 30, 2021 | -500,000.00 |
| Jun 30, 2021 | -1.80 Mn |